Compare NFG & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NFG | CRL |
|---|---|---|
| Founded | 1902 | 1947 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil/Gas Transmission | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.8B | 8.3B |
| IPO Year | 1997 | 1999 |
| Metric | NFG | CRL |
|---|---|---|
| Price | $96.13 | $155.30 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 13 |
| Target Price | $91.20 | ★ $197.58 |
| AVG Volume (30 Days) | 636.1K | ★ 1.1M |
| Earning Date | 04-29-2026 | 05-19-2026 |
| Dividend Yield | ★ 2.28% | N/A |
| EPS Growth | ★ 576.19 | N/A |
| EPS | ★ 1.98 | N/A |
| Revenue | ★ $2,277,541,000.00 | $1,857,601,000.00 |
| Revenue This Year | $13.10 | $2.11 |
| Revenue Next Year | $31.56 | $2.95 |
| P/E Ratio | $47.38 | ★ N/A |
| Revenue Growth | ★ 17.11 | 10.48 |
| 52 Week Low | $69.93 | $91.86 |
| 52 Week High | $94.69 | $228.88 |
| Indicator | NFG | CRL |
|---|---|---|
| Relative Strength Index (RSI) | 75.62 | 34.31 |
| Support Level | $85.48 | $145.97 |
| Resistance Level | N/A | $157.42 |
| Average True Range (ATR) | 1.89 | 6.92 |
| MACD | 0.20 | -0.64 |
| Stochastic Oscillator | 95.66 | 12.42 |
National Fuel Gas Co is a diversified energy company involved in natural gas production, gathering, transportation, distribution, and marketing. It operates through three segments: Integrated Upstream and Gathering, Pipeline and Storage, and Utility. The majority of revenue comes from the Integrated Upstream and Gathering segment, which focuses on Seneca's natural gas exploration and development in the Appalachian region and Midstream operations supporting gas processing and gathering. The Pipeline and Storage segment transports and stores natural gas for customers in the northeastern United States and Canada, while the Utility segment supplies natural gas to retail customers in western New York and northwestern Pennsylvania. the company opeartes in United States.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.